CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness
Open Access
- 15 September 2025
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 39 (12) , 3015-3025
Abstract
GATA2 deficiency is a monogenic transcriptopathy disorder characterized by bone marrow failure (BMF), immunodeficiency, and a high risk of developing myelodysplastic neoplasms (MDS) and acute myeloid leukemia (AML). Although informative mouse models have been developed, the mechanisms by which GATA2 haploinsufficiency drives disease initiation in humans remain incompletely understood. To address this, we developed a novel humanized model using CRISPR/Cas9 technology to knock-in GATA2-R398W variant in primary cord blood CD34⁺ cells. Additionally, we introduced specific mutations in SETBP1 and ASXL1 to model distinct premalignant stages of GATA2 deficiency. Through clonal competition and serial transplantation assays, we demonstrated that human CD34+ cells harboring the GATA2 mutation exhibit significantly reduced fitness in vivo when compete with wild-type cells. Notably, this fitness disadvantage persists even when GATA2 mutations are combined with oncogenic SETBP1 and ASXL1 drivers, underscoring the dominant, deleterious effect of GATA2 deficiency on hematopoietic stem cell function. Functional in vitro analyses revealed that GATA2-R398W mutation impairs cell proliferation, disrupts cell cycle progression, and induces mitotic defects, which may contribute to hematopoietic stem/progenitor cell loss and impaired self-renewal. Transcriptomic profiles of GATA2-mutant cells revealed that these functional defects are associated with reduced HSC self-renewal capacity and upregulation of the pre-aging phenotype. Our work highlights the feasibility of generating a human GATA2 deficiency model suitable for studying the biological consequences of various GATA2 variants and the generation of a platform to test potential phenotype-rescuing therapeutics.Keywords
This publication has 64 references indexed in Scilit:
- Discovering Hematopoietic Mechanisms through Genome-wide Analysis of GATA Factor Chromatin OccupancyMolecular Cell, 2009
- Cep68 and Cep215 (Cdk5rap2) are required for centrosome cohesionJournal of Cell Science, 2007
- Aging Hematopoietic Stem Cells Decline in Function and Exhibit Epigenetic DysregulationPLOS Biology, 2007
- Hematopoietic stem cell aging: Mechanism and consequenceExperimental Gerontology, 2007
- Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasisBlood, 2005
- GATA-2 Plays Two Functionally Distinct Roles during the Ontogeny of Hematopoietic Stem CellsJournal of Experimental Medicine, 2004
- Decreased expression of the INK4 family of cyclin‐dependent kinase inhibitors in Wilms tumorGenes, Chromosomes and Cancer, 2000
- Control of Cell Proliferation by Myc Family GenesMolecules and Cells, 1999
- Structural and Functional Analysis of Cyclin-Dependent Kinase Inhibitor Genes(CDKN2A, CDKN2B, and CDKN2C) in NeuroblastomaPediatric Research, 1998
- An early haematopoietic defect in mice lacking the transcription factor GATA-2Nature, 1994